The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in the waning days of the Biden administration. “While it is crucial ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Neil Vaccines are medicine which protect the human body by making it immune from a certain disease. Now, there’s been a sudden and important discovery – a breakthrough - in the development of a new ...

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a personalized mRNA vaccine, which offers new hope. This pancreatic cancer ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...